Therefore, we provide physiological confirmation of the hypothesis that IGFs signaling in RCC is mediated mainly by circulating ligand proteins (IGF1 and IGF2) from sources other than RCC cancer tumor itself, as suggested before (Schips et al. 2004). Here, IGF2 is linked to renal cell adenocarcinoma.